Published in Proc Natl Acad Sci U S A on May 29, 2001
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study. J Clin Oncol (2009) 2.78
The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer. Cell Cycle (2012) 1.56
In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling. Cancer Cell (2013) 1.42
Interferon-gamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles. Blood (2005) 1.30
Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis. J Natl Cancer Inst (2008) 1.18
Serine/arginine protein-specific kinase 2 promotes leukemia cell proliferation by phosphorylating acinus and regulating cyclin A1. Cancer Res (2008) 1.10
Expression of retinoic acid receptor alpha in the germline is essential for proper cellular association and spermiogenesis during spermatogenesis. Development (2009) 1.00
Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen. Blood (2012) 0.99
Dissecting the role of p53 phosphorylation in homologous recombination provides new clues for gain-of-function mutants. Nucleic Acids Res (2008) 0.98
Inhibitor of cyclin-dependent kinase (CDK) interacting with cyclin A1 (INCA1) regulates proliferation and is repressed by oncogenic signaling. J Biol Chem (2011) 0.94
NGF inhibits human leukemia proliferation by downregulating cyclin A1 expression through promoting acinus/CtBP2 association. Oncogene (2009) 0.89
Cyclin A1 regulates the interactions between mouse haematopoietic stem and progenitor cells and their niches. Cell Cycle (2015) 0.86
Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer. PLoS One (2013) 0.84
Regulation of APC(Cdh1) E3 ligase activity by the Fbw7/cyclin E signaling axis contributes to the tumor suppressor function of Fbw7. Cell Res (2013) 0.83
Comparative pathogenesis of epsilonretroviruses. J Virol (2003) 0.83
Function of the A-type cyclins during gametogenesis and early embryogenesis. Results Probl Cell Differ (2011) 0.81
Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group. Leukemia (2016) 0.79
SERPINB13 is a novel RUNX1 target gene. Biochem Biophys Res Commun (2011) 0.76
A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis. PLoS One (2015) 0.75
Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells. Eur J Cancer (2016) 0.75
G1 phase progression: cycling on cue. Cell (1994) 11.62
Oncogenic transcription factors in the human acute leukemias. Science (1997) 6.45
A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1997) 3.20
Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Blood (1997) 2.72
Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci U S A (1997) 2.47
Cyclin A1 is required for meiosis in the male mouse. Nat Genet (1998) 2.28
The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood (1996) 1.98
A distinct cyclin A is expressed in germ cells in the mouse. Development (1996) 1.84
Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines. Cancer Res (1997) 1.44
Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Nat Genet (1997) 1.34
Regulation of meiosis during mammalian spermatogenesis: the A-type cyclins and their associated cyclin-dependent kinases are differentially expressed in the germ-cell lineage. Dev Biol (1999) 1.32
A role for cyclin A1 in the activation of MPF and G2-M transition during meiosis of male germ cells in mice. Dev Biol (2000) 1.26
Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice. Proc Natl Acad Sci U S A (1994) 1.16
Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML. Proc Natl Acad Sci U S A (2000) 1.14
Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis (1997) 1.14
Expression of the murine Hoxa4 gene requires both autoregulation and a conserved retinoic acid response element. Development (1998) 1.10
Cyclin A1 expression in leukemia and normal hematopoietic cells. Blood (1999) 1.09
Sequences 5' of the homeobox of the Hox-1.4 gene direct tissue-specific expression of lacZ during mouse development. Development (1993) 1.08
The aberrant fusion proteins PML-RAR alpha and PLZF-RAR alpha contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia. Blood (2000) 0.94
Overexpression of cyclin E in acute myelogenous leukemia. Blood (1997) 0.94
Cell cycle regulation of hematopoietic stem cells. Hum Cell (1998) 0.90
Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage. Blood (1996) 0.90
Relapse of chronic myeloid leukaemia 14 years after allogeneic bone marrow transplantation. Bone Marrow Transplant (1999) 0.89
Cyclin A1 is predominantly expressed in hematological malignancies with myeloid differentiation. Leukemia (1998) 0.88
Lineage-specific regulation of cell cycle gene expression in differentiating myeloid cells. J Cell Sci (1994) 0.88
The localization of p34cdc2 in the cells of normal, hyperplastic, and malignant epithelial and lymphoid tissues of the oral cavity. J Pathol (1996) 0.87
Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p16INK4A) in childhood acute lymphoblastic leukemia. Int J Cancer (1997) 0.86
Modeling acute promyelocytic leukemia in the mouse: new insights in the pathogenesis of human leukemias. Blood Cells Mol Dis (2001) 0.79
Expression of cyclins and cdks throughout murine carcinogenesis. Cell Mol Biol (Noisy-le-grand) (1999) 0.78
Pten is essential for embryonic development and tumour suppression. Nat Genet (1998) 13.41
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet (1998) 8.20
The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature (1999) 7.85
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med (1998) 6.83
The multiple roles of PTEN in tumor suppression. Cell (2000) 6.71
Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet (2001) 5.92
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet (1997) 5.55
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature (2000) 4.90
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res (2000) 4.79
Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Mol Cell Biol (1999) 4.42
The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene (2008) 4.39
Impaired Fas response and autoimmunity in Pten+/- mice. Science (1999) 4.25
Role of SUMO-1-modified PML in nuclear body formation. Blood (2000) 4.05
Role of PML in cell growth and the retinoic acid pathway. Science (1998) 3.82
The transcriptional role of PML and the nuclear body. Nat Cell Biol (2000) 3.80
PML is essential for multiple apoptotic pathways. Nat Genet (1998) 3.75
Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med (2001) 3.62
Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. Nat Genet (1998) 2.97
The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene (1995) 2.80
Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst (1998) 2.64
BCL-6 regulates chemokine gene transcription in macrophages. Nat Immunol (2000) 2.58
Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci U S A (1997) 2.47
Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature (1994) 2.45
Interstitial cells of Cajal mediate enteric inhibitory neurotransmission in the lower esophageal and pyloric sphincters. Gastroenterology (1998) 2.42
Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J (2000) 2.38
Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. Mech Dev (1998) 2.28
Cyclin A1 is required for meiosis in the male mouse. Nat Genet (1998) 2.28
The function of PML in p53-dependent apoptosis. Nat Cell Biol (2000) 2.24
Genetic and cytogenetic localisation of the homeo box containing genes on mouse chromosome 6 and human chromosome 7. EMBO J (1986) 2.19
Plzf regulates limb and axial skeletal patterning. Nat Genet (2000) 2.14
Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF. Oncogene (2011) 2.10
Acute promyelocytic leukemia: from genetics to treatment. Blood (1994) 2.09
Novel human and mouse homologs of Saccharomyces cerevisiae DNA polymerase eta. Genomics (1999) 2.06
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. J Clin Invest (2001) 2.00
Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J Neurosci (1996) 1.97
A role for PML and the nuclear body in genomic stability. Oncogene (1999) 1.97
The theory of APL revisited. Curr Top Microbiol Immunol (2007) 1.96
Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching. Mol Cell Biol (1999) 1.91
GermOnline, a cross-species community knowledgebase on germ cell differentiation. Nucleic Acids Res (2004) 1.90
Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus. Proc Natl Acad Sci U S A (1991) 1.90
Transcription and accurate polyadenylation in vitro of RNA from the major late adenovirus 2 transcription unit. Cell (1982) 1.86
Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest (1997) 1.86
Evidence for BLM and Topoisomerase IIIalpha interaction in genomic stability. Hum Mol Genet (2001) 1.85
A distinct cyclin A is expressed in germ cells in the mouse. Development (1996) 1.84
A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins. Nat Genet (1999) 1.78
p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). J Exp Med (2001) 1.73
Haploid expression of a unique c-abl transcript in the mouse male germ line. Mol Cell Biol (1985) 1.71
Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. Blood (1997) 1.69
Regulation of apoptosis by PML and the PML-NBs. Oncogene (2008) 1.67
Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ (2009) 1.67
Role of promyelocytic leukemia (PML) protein in tumor suppression. J Exp Med (2001) 1.63
Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene (1992) 1.59
Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. Proc Natl Acad Sci U S A (2000) 1.57
The chromosome make-up of mouse embryonic stem cells is predictive of somatic and germ cell chimaerism. Transgenic Res (1997) 1.54
Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J Biol Chem (1998) 1.48
PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J (2001) 1.47
The effect of age and cerebral ischemia on diffusion-weighted proton MR spectroscopy of the human brain. AJNR Am J Neuroradiol (2011) 1.47
Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias. J Exp Med (1990) 1.47
Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene. Blood (1999) 1.46
Distinct developmental patterns of c-mos protooncogene expression in female and male mouse germ cells. Proc Natl Acad Sci U S A (1987) 1.46
The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux. Cancer Res (2001) 1.45
Specific expression of soluble adenylyl cyclase in male germ cells. Mol Reprod Dev (2000) 1.45
Isolation of a mouse cDNA coding for a developmentally regulated, testis-specific transcript containing homeo box homology. EMBO J (1986) 1.45
Homeotic transformation of cervical vertebrae in Hoxa-4 mutant mice. Proc Natl Acad Sci U S A (1994) 1.43
Mzf1 controls cell proliferation and tumorigenesis. Genes Dev (2001) 1.43
Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis. J Exp Med (2000) 1.43
Expression and potential role of Fsrg1, a murine bromodomain-containing homologue of the Drosophila gene female sterile homeotic. J Cell Sci (1998) 1.38
Fragmented condensate ground state of trapped weakly interacting bosons in two dimensions. Phys Rev Lett (2001) 1.36
Regulation of Pax3 transcriptional activity by SUMO-1-modified PML. Oncogene (2001) 1.35
Compound mutants for the paralogous hoxa-4, hoxb-4, and hoxd-4 genes show more complete homeotic transformations and a dose-dependent increase in the number of vertebrae transformed. Genes Dev (1995) 1.34
Two critical hits for promyelocytic leukemia. Mol Cell (2000) 1.33
The pseudorabies virus UL28 protein enters the nucleus after coexpression with the herpes simplex virus UL15 protein. J Virol (1997) 1.32
Regulation of meiosis during mammalian spermatogenesis: the A-type cyclins and their associated cyclin-dependent kinases are differentially expressed in the germ-cell lineage. Dev Biol (1999) 1.32
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J Exp Med (1996) 1.29
Role of PML and PML-RARalpha in Mad-mediated transcriptional repression. Mol Cell (2001) 1.29
Visualization of nascent RNA transcripts and simultaneous transcription and replication in viral nucleoprotein complexes from adenovirus 2-infected HeLa cells. J Mol Biol (1981) 1.27
A role for cyclin A1 in the activation of MPF and G2-M transition during meiosis of male germ cells in mice. Dev Biol (2000) 1.26
Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features. J Neuropathol Exp Neurol (2000) 1.26
A family of Shc related proteins with conserved PTB, CH1 and SH2 regions. Oncogene (1996) 1.26
Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1992) 1.24
Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer. Cancer Res (1999) 1.23
Role of retinoid signaling in the regulation of spermatogenesis. Cytogenet Genome Res (2004) 1.23
Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome. Leukemia (2006) 1.22
Neurotransmission in lower esophageal sphincter of W/Wv mutant mice. Am J Physiol Gastrointest Liver Physiol (2009) 1.21
Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner. Blood (1998) 1.20
Analysis of genomic rearrangements associated with EGRFvIII expression suggests involvement of Alu repeat elements. Neuro Oncol (2000) 1.20
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. J Pathol (2006) 1.20
Prevalence and associations of anisometropia and aniso-astigmatism in a population based sample of 6 year old children. Br J Ophthalmol (2006) 1.19
Phosphoinositide 3-kinase-dependent membrane recruitment of p62(dok) is essential for its negative effect on mitogen-activated protein (MAP) kinase activation. J Exp Med (2001) 1.19
Identification and sequence analysis of a new member of the mouse HSP70 gene family and characterization of its unique cellular and developmental pattern of expression in the male germ line. Mol Cell Biol (1988) 1.19
Identification of PTEN at the ER and MAMs and its regulation of Ca(2+) signaling and apoptosis in a protein phosphatase-dependent manner. Cell Death Differ (2013) 1.19
Differential expression of the mouse homeobox-containing gene Hox-1.4 during male germ cell differentiation and embryonic development. Proc Natl Acad Sci U S A (1987) 1.17
Developmental-stage-specific expression of the hsp70 gene family during differentiation of the mammalian male germ line. Mol Cell Biol (1987) 1.15
Identification of a mouse B-type cyclin which exhibits developmentally regulated expression in the germ line. Mol Reprod Dev (1992) 1.14
Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J Virol (2001) 1.14
Isolation of the murine cyclin B2 cDNA and characterization of the lineage and temporal specificity of expression of the B1 and B2 cyclins during oogenesis, spermatogenesis and early embryogenesis. Development (1993) 1.13
Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy. Endocrinology (2004) 1.13